"Congressman Steve Cohen (D-TN) Tells DEA To Reschedule Marijuana 'As Swiftly As Possible'; Says "I Urge You, In The Strongest Possible Way, To Follow Through On HHS's Recommendation" To Move Cannabis To Schedule III." - Marijuana Moment
Portfolio Pulse from Benzinga Newsdesk
Rep. Steve Cohen (D-TN) has urged the DEA to reschedule marijuana to Schedule III, following the HHS's recommendation. The DEA has the final authority and is currently reviewing the matter. The rescheduling debate has received input from various stakeholders, including former U.S. attorneys, governors, and DEA heads, with differing opinions on the best course of action. The DEA is also addressing other controlled substances, such as psychedelics and THC in Georgia pharmacies.
January 05, 2024 | 4:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The ETFMG Alternative Harvest ETF (MJ) could be impacted by the DEA's decision on marijuana rescheduling, potentially increasing market optimism for the cannabis sector.
As an ETF focused on the cannabis industry, MJ's holdings could benefit from a more favorable legal environment if marijuana is rescheduled, potentially leading to increased investment and growth in the sector.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 70
POSITIVE IMPACT
AdvisorShares Pure US Cannabis ETF (MSOS) could see a positive impact from the DEA's potential rescheduling of marijuana, which may lead to increased investor confidence in the U.S. cannabis market.
MSOS, which invests in U.S. cannabis companies, could benefit from a rescheduling decision that would likely improve the legal landscape and investment prospects for the industry.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 70